Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SQ109 in H. pylori infection
NCT01252108Phase 2Withdrawn
- Sponsor
- Sequella, Inc.
- Start
- Mar 2012
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of SQ109 in Helicobacter pylori infection, sponsored by Sequella, Inc.. Planned start Mar 2012; status: withdrawn.
02
Drugs
SQ109
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01252108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252108.